Today's cataract patients are on the go. Many are still working and having good vision is essential to helping them stay active and involved. Patient satisfaction with cataract surgery hinges on gathering accurate lifestyle information and matching it with clinically appropriate surgical options. Truly successful outcomes, as measured from the patient's perspective, simply cannot be achieved without knowing the patient's lifestyle and individual visual demands.
Most patients have very little knowledge of the types of IOLs (intraocular lenses) available to them. Patients often understand they have astigmatism but they don't know what their choices are to compensate for it with IOL selection. Addressing astigmatism is a key aspect in providing a true refractive correction as part of the cataract procedure. Toric (astigmatic) IOLs correct two eye conditions; cataracts and astigmatism. Toric IOLs deliver crisp, clearer distance vision and may reduce dependence on glasses to see at a distance. Toric IOL's are proven to deliver the highest quality visual outcome versus a basic lens option.
Without complete and successful treatment of astigmatism, the goal of achieving excellent uncorrected distance vision and reducing spectacle dependence for distance vision cannot be met.
Alcon's new consumer campaign at mycataracts.com helps to explain the concept that correcting astigmatism at the time of cataract surgery is like getting two birds with one stone. Alcon's "My Cataracts" YouTube channel also helps to deliver the demand for online learning. The "Two Birds" educational video has already surpassed 1.6 million views. The new My Cataract call center (1-844-MYCATARACT) allows patients to communicate on their own terms. This patient call center is staffed with dedicated, trained cataract counselors and offers a best-in-class patient experience.
We need to engage patients early and often to ensure that we make a positive impact on the patient's final choice and enable them to feel prepared to make what is for the majority of people a once in a lifetime decision.
Article excerpted from Review of Optometry May 2017 David Geffen, OD